Has, CristinaLiu, LuBolling, MariekeCharlesworth, Alexandra V.Hachem, May ElEscámez, María JoséFuentes, IgnaciaBüche, SarahHiremagalore, RaviPohla-Gubo, GabrieleAkker, Peter van denWertheim-Tysarowska, KatarzynaZambruno, Giovanna2020-04-012020-04-012019British Journal of Dermatology. 2020 Mar;182(3):574-592http://hdl.handle.net/11447/3197https://doi.org/10.1111/bjd.18128The overall objective of this guideline is to provide the user with information on the laboratory diagnosis of inherited epidermolysis bullosa (EB) to improve outcomes (Table 1). An accurate diagnosis and subclassification of EB enables (i) early prognostication of disease severity, (ii) decision making for patient management, (iii) informed genetic counselling for the patient and family and DNA‐based prenatal or preimplantation genetic diagnosis, (iv) long‐term surveillance and management of possible complications, (v) inclusion in clinical trials and (vi) precision medicine.60 p.enMolecular diagnosisGenetic diagnosisGenodermatosisSkin fragilityEpidermolysis bullosaArticle